Allergan is recalling 8 bottles of NORCO (hydrocodone bitartrate and acetaminophen) 10 mg/325 mg tablets. These prescription pain medications were distributed in 100-count bottles and are being recalled because the primary label does not show the required "CII" symbol, which indicates it is a Schedule II controlled substance. This error affects only a very small number of bottles distributed nationwide, and there have been no reports of injuries or quality issues with the medicine itself.
The missing "CII" label could lead to a misunderstanding of the drug's classification and the specific handling or security requirements required for controlled substances. While the medication itself is safe to use if prescribed, the labeling error fails to meet federal requirements for identifying highly regulated drugs.
Contact your pharmacist for a refund or replacement medication.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.